Figure 2 displays the regulatory action of PD-L2 expression. Like PD-L1, PD-L2 crucially modulates T cell activation, proliferation, and immune escape by human tumors (47). In glioma patients, PD-L2 expression could report worse clinical outcomes (43). Here, PDCD1LG2 is linked to central nervous system cancer.